1st Quarter - Report

ARENTFOX SCHIFF LLP for AMERICAN PHARMACY COOPERATIVE, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Prescription drug pricing generally Pharmacy Benefit Manager (PBM) reform generally S. 2973 (Modernizing and Ensuring PBM Accountability Act), all provisions S. 1339 (Pharmacy Benefit Manager Reform Act), regarding Pharmacy Benefit Manager (PBM) reform S. 3430 (Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023), regarding Pharmacy Benefit Manager (PBM) reform H.R. 5378 (Lower Costs, More Transparency Act), regarding Pharmacy Benefit Manager (PBM) reform H.R. 6283 (DRUG Act), regarding Pharmacy Benefit Manager (PBM) reform

LobbyistCovered position, as disclosed
CISSY JACKSON —
DANIEL SJOSTEDT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2973 (118th), H.R. 6283 (118th), H.R. 5378 (118th), S. 3430 (118th), S. 1339 (118th)

Medicare/Medicaid MMM

Policies regarding transparency in prescription drug pricing and patient access to care in Medicare, Medicaid, and other insurance

LobbyistCovered position, as disclosed
CISSY JACKSON —
DANIEL SJOSTEDT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.